InflaRx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab.
CEONiels Christoph Riedemann
CEONiels Christoph Riedemann
Employees66
Employees66
HeadquartersJena, Thueringen
HeadquartersJena, Thueringen
Founded2007
Founded2007
Employees66
Employees66
IFRX Key Statistics
Market cap75.96M
Market cap75.96M
Price-Earnings ratio-1.52
Price-Earnings ratio-1.52
Dividend yield—
Dividend yield—
Average volume144.81K
Average volume144.81K
High today$1.41
High today$1.41
Low today$1.28
Low today$1.28
Open price$1.39
Open price$1.39
Volume236.31K
Volume236.31K
52 Week high$5.20
52 Week high$5.20
52 Week low$1.14
52 Week low$1.14